Form 8-K - Current report:
SEC Accession No. 0001728117-24-000059
Filing Date
2024-05-24
Accepted
2024-05-24 16:30:57
Documents
13
Period of Report
2024-05-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K goss-20240522.htm   iXBRL 8-K 30947
  Complete submission text file 0001728117-24-000059.txt   154034

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20240522.xsd EX-101.SCH 1913
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20240522_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20240522_pre.xml EX-101.PRE 12516
16 EXTRACTED XBRL INSTANCE DOCUMENT goss-20240522_htm.xml XML 2716
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 24984918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)